• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/27/15

    • 30-Day SEC Yield1

      1.61%
    • Total Net Assets

      $386.7M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2015
  • Portfolio Composition (%)
    as of 02/27/15

    • % of Net Assets
    • Stocks

      99.92
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.08
  • Download All HoldingsAll Holdings (%) as of 02/27/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    351,402
    35,983,5659.30
    Johnson & Johnson
    JNJ US
    317,553
    32,552,3588.42
    Pfizer Inc
    PFE US
    757,859
    26,009,7216.73
    Glaxosmithkline Plc
    GSK US
    418,479
    19,844,2745.13
    Valeant Pharmaceuticals International I
    VRX US
    100,288
    19,804,8745.12
    Sanofi
    SNY US
    396,854
    19,390,2865.01
    Novo Nordisk A/S
    NVO US
    397,546
    18,982,8224.91
    Actavis Plc
    ACT US
    63,287
    18,439,3004.77
    Allergan Inc/United States
    AGN US
    77,961
    18,144,6434.69
    Merck & Co Inc
    MRK US
    303,429
    17,762,7344.59
    Abbott Laboratories
    ABT US
    369,160
    17,487,1094.52
    Bristol-Myers Squibb Co
    BMY US
    276,310
    16,832,8054.35
    Abbvie Inc
    ABBV US
    269,304
    16,292,8924.21
    Eli Lilly & Co
    LLY US
    230,537
    16,176,7814.18
    Shire Plc
    SHPG US
    65,462
    15,835,9124.09
    Astrazeneca Plc
    AZN US
    222,460
    15,327,4943.96
    Mckesson Corp
    MCK US
    64,733
    14,804,4373.83
    Teva Pharmaceutical Industries Ltd
    TEVA US
    257,049
    14,656,9343.79
    Zoetis Inc
    ZTS US
    145,337
    6,698,5821.73
    Mylan Inc/Pa
    MYL US
    113,862
    6,527,1391.69
    Perrigo Co
    PRGO US
    40,812
    6,304,2301.63
    Hospira Inc
    HSP US
    44,812
    3,922,8421.01
    Mallinckrodt Plc
    MNK US
    27,884
    3,254,6200.84
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    37,961
    3,249,4620.84
    Salix Pharmaceuticals Ltd
    SLXP US
    13,454
    2,114,9690.55
    Other/Cash
    319,8130.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.